COVID-19: Implications for People with Chagas Disease

Imagem de Miniatura
Arquivos
art_ZAIDEL_COVID19_Implications_for_People_with_Chagas_Disease_2020.PDF (1.47 MB)
Citações na Scopus
38
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
UBIQUITY PRESS LTD
Autores
ZAIDEL, Ezequiel Jose
FORSYTH, Colin J.
NOVICK, Gabriel
MARCUS, Rachel
RIBEIRO, Antonio Luiz P.
PINAZO, Maria-Jesus
MORILLO, Carlos A.
ECHEVERRIA, Luis Eduardo
BUEKENS, Pierre
Citação
GLOBAL HEART, v.15, n.1, article ID 69, 15p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
As the global COVID-19 pandemic advances, it increasingly impacts those vulnerable populations who already bear a heavy burden of neglected tropical disease. Chagas disease (CD), a neglected parasitic infection, is of particular concern because of its potential to cause cardiac, gastro-intestinal, and other complications which could increase susceptibility to COVID-19. The over one million people worldwide with chronic Chagas cardiomyopathy require special consideration because of COVID-19's potential impact on the heart, yet the pandemic also affects treatment provision to people with acute or chronic indeterminate CD. In this document, a follow-up to the WHF-IASC Roadmap on CD, we assess the implications of coinfection with SARS-CoV-2 and Trypanosoma cruzi, the etiological agent of CD. Based on the limited evidence available, we provide preliminary guidance for testing, treatment, and management of patients affected by both diseases, while highlighting emerging healthcare access challenges and future research needs.
Palavras-chave
COVID-19, Chagas Disease, Neglected Tropical Disease
URI
https://observatorio.fm.usp.br/handle/OPI/39232
Referências
  1. Alvar J, 2020, SEMIN IMMUNOPATHOL, V42, P231, DOI 10.1007/s00281-020-00796-y
  2. [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
  3. Baqui P, 2020, LANCET GLOB HEALTH, V8, P1018, DOI 10.1016/S2214-109X(20)30285-0
  4. Barros ML, 2011, REV SOC BRAS MED TRO, V44, P213, DOI 10.1590/s0037-86822011005000020
  5. Batista A, 2020, 1 NOIS
  6. Benziger CP, 2017, CARDIOL CLIN, V35, P31, DOI 10.1016/j.ccl.2016.08.013
  7. Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171
  8. Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
  9. Buekens P, 2020, LANCET GLOB HEALTH, V8, pE877, DOI 10.1016/S2214-109X(20)30206-0
  10. Campana C, 1996, CLIN PHARMACOKINET, V30, P141, DOI 10.2165/00003088-199630020-00004
  11. Carlier Y, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007694
  12. Centers for Disease Control, PROV DEATH COUNTS CO
  13. Chakraborty Abhijit, 2012, Clin Pharmacokinet, V51, pe1, DOI 10.2165/11599820-000000000-00000
  14. Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
  15. Alves RMD, 2009, REV SOC BRAS MED TRO, V42, P622, DOI 10.1590/S0037-86822009000600002
  16. de Araujo FF, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00663-w
  17. Santos-Neto Leopoldo Luiz dos, 2003, Rev. Soc. Bras. Med. Trop., V36, P613, DOI 10.1590/S0037-86822003000500012
  18. Dutra WO, 2014, PARASITE IMMUNOL, V36, P377, DOI 10.1111/pim.12107
  19. Echeverria LE, 2020, GLOB HEART, V15, DOI 10.5334/gh.484
  20. Fabbro DL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003312
  21. Forsyth CJ, 2016, CLIN INFECT DIS, V63, P1056, DOI 10.1093/cid/ciw477
  22. Cianciulli TF, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0457-2019
  23. Furtado RG, 2015, ARQ BRAS CARDIOL, V104, P209, DOI 10.5935/abc.20140197
  24. Gosain R, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-00934-7
  25. Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
  26. Howard EJ, 2014, BJOG-INT J OBSTET GY, V121, P22, DOI 10.1111/1471-0528.12396
  27. Imam Z, 2020, J INTERN MED, V288, P469, DOI 10.1111/joim.13119
  28. Jackson Y, 2012, TROP MED INT HEALTH, V17, P595, DOI 10.1111/j.1365-3156.2012.02965.x
  29. Janssen Biotech, FULL PRESCR INF 2014
  30. Janssen Pharmaceutical Companies, 2019, PREZCOBIX DAR COB TA
  31. Jin X, 2020, GUT, V69, P1002, DOI 10.1136/gutjnl-2020-320926
  32. Kaplinski M, 2015, CLIN INFECT DIS, V61, P918, DOI 10.1093/cid/civ446
  33. Keating SM, 2015, INT J CARDIOL, V199, P451, DOI 10.1016/j.ijcard.2015.07.040
  34. Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
  35. Libby P, 2020, JACC-BASIC TRANSL SC, V5, P537, DOI 10.1016/j.jacbts.2020.04.001
  36. Lill J, 2000, AM J HEALTH-SYST PH, V57, P1579, DOI 10.1093/ajhp/57.17.1579
  37. Lima-Costa MF, 2010, INT J CARDIOL, V145, P362, DOI 10.1016/j.ijcard.2010.02.036
  38. Lin L, 2020, GUT, V69, P997, DOI 10.1136/gutjnl-2020-321013
  39. Lopez L, 2006, REV ESP CARDIOL, V59, P50, DOI 10.1157/13083649
  40. Manne-Goehler J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005033
  41. Martins-Melo FR, 2014, ACTA TROP, V130, P167, DOI 10.1016/j.actatropica.2013.10.002
  42. Milazzo L, 2013, EUR J CLIN PHARMACOL, V69, P743, DOI 10.1007/s00228-012-1397-0
  43. Moccia F, 2020, GEROSCIENCE, V42, P1021, DOI 10.1007/s11357-020-00198-w
  44. Montalvan V, 2020, CLIN NEUROL NEUROSUR, V194, DOI 10.1016/j.clineuro.2020.105921
  45. Mustafa NM, 2020, J CLIN VIROL, V128
  46. Nath A, 2020, NEUROLOGY, V94, P809, DOI 10.1212/WNL.0000000000009455
  47. Novartis Pharmaceuticals Corporation, 2012, ILARIS CAN FULL PRES
  48. Nunes MCP, 2018, EUR HEART J-CARD IMG, V19, P459, DOI 10.1093/ehjci/jex154
  49. Oliveira Junior LR, 2018, AME MED J, DOI [10.21037/amj.2018.07.01, DOI 10.21037/AMJ.2018.07.01]
  50. Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
  51. Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
  52. Pan American Health Organization, 2019, GUID DIAGN TREATM CH
  53. Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
  54. Patheon Italia, 2018, GAMIFANTTM EM LZSG I
  55. Nunes MCP, 2018, CIRCULATION, V138, pE169, DOI 10.1161/CIR.0000000000000599
  56. Pessoa-Amorim G, 2020, EUR HEART J-QUAL CAR, V6, P210, DOI 10.1093/ehjqcco/qcaa046
  57. Pfizer Inc, 2017, RAPAMUNE
  58. Pinazo M.J., 2016, PLOS NEGLECT TROP D, V10, P1, DOI 10.1371/J0URNAL.PNTD.0004269
  59. Pinazo MJ, 2010, ANTIMICROB AGENTS CH, V54, P4896, DOI 10.1128/AAC.00537-10
  60. Rassi A, 1999, Rev Soc Bras Med Trop, V32, P475, DOI 10.1590/S0037-86821999000500002
  61. Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
  62. Regueiro A, 2013, INT J CARDIOL, V165, P107, DOI 10.1016/j.ijcard.2011.07.089
  63. Reza N, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007219
  64. Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109
  65. Salaroglio IC, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0967-0
  66. Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629
  67. Schett G, 2020, NAT REV IMMUNOL, V20, P271, DOI 10.1038/s41577-020-0312-7
  68. Shin J, 2007, PHARMACOTHERAPY, V27, P874, DOI 10.1592/phco.27.6.874
  69. Siripanthong B, 2020, HEART RHYTHM, V17, P1463, DOI 10.1016/j.hrthm.2020.05.001
  70. Sosa-Estani S, 2009, REV SOC BRAS MED TRO, V42, P484, DOI 10.1590/S0037-86822009000500002
  71. de Sousa AS, 2008, ARQ BRAS CARDIOL, V91, P280
  72. da Silva GMS, 2018, J ANTIMICROB CHEMOTH, V73, P1115, DOI 10.1093/jac/dkx505
  73. Tanowitz HB, 2015, EXPERT REV CARDIOVAS, V13, P1393, DOI 10.1586/14779072.2015.1103648
  74. Torreao JA, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0200-7
  75. United Nations, 2020, WORLD EC SIT PROSP M
  76. University of California-San Francisco, 2019, INT AM ANT
  77. Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041
  78. Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
  79. Viotti R, 2009, REV ESP CARDIOL, V62, P1224, DOI 10.1016/S0300-8932(09)73074-X
  80. Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
  81. WHO, 2017, 4 WHO REP NEGL TROP
  82. Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
  83. Zaidel EJ, 2020, MEDICINA-BUENOS AIRE, V80, P271
  84. Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
  85. Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
  86. Zingone F, 2020, LANCET GASTROENTEROL, V5, P525, DOI 10.1016/S2468-1253(20)30085-6

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - LIM/48
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/10